Accuracy of ChatGPT in Common Gastrointestinal Diseases: Impact for Patients and Providers.

Publisher: W.B. Saunders for the American Gastroenterological Association Country of Publication: United States NLM ID: 101160775 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-7714 (Electronic) Linking ISSN: 15423565 NLM ISO Abbreviation: Clin Gastroenterol Hepatol Subsets: MEDLINE

Original Publication: Philadelphia, PA : W.B. Saunders for the American Gastroenterological Association, 2003-

Gastrointestinal Diseases*/diagnosis; Humans ; Female ; Male ; Middle Aged ; Adult ; Physician-Patient Relations ; Aged ; Patient Education as Topic/methods ; Software

Since its release in 2022, Chat Generative Pre-Trained Transformer (ChatGPT) became the most rapidly expanding consumer software application in history, ¹ and its role in medicine is underscored by its potential to enhance patient education and physician-patient communication. Previous studies in gastroenterology and hepatology have focused primarily on the earlier Generative Pre-Trained Transformer 3 (GPT-3) model, with none investigating ChatGPT's ability to generate supportive references for its responses, or its applicability as a physician educational tool. ^2-6 Our study evaluated the accuracy of the more recent ChatGPT, powered by GPT-4, in addressing frequently asked questions by patients on irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), colonoscopy and colorectal cancer (CRC) screening, questions on CRC screening from a physician perspective, and reference generation and suitability.
(Copyright © 2024 AGA Institute. Published by Elsevier Inc. All rights reserved.)

Date Created: 20231120 Date Completed: 20240526 Latest Revision: 20240526

20240527

10.1016/j.cgh.2023.11.008

37984563